Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Abdominal Radiology
Erschienen in: Abdominal Radiology 9/2016

03.05.2016 | Pictorial Essay

Clinical implications for imaging of vascular invasion in hepatocellular carcinoma

verfasst von: Akshay D. Baheti, Gregor M. Dunham, Christopher R. Ingraham, Mariam Moshiri, Chandana Lall, James O. Park, David Li, Douglas S. Katz, David C. Madoff, Puneet Bhargava

Erschienen in: Abdominal Radiology | Ausgabe 9/2016

Einloggen, um Zugang zu erhalten

Abstract

Hepatocellular carcinoma (HCC) is the second largest cause of cancer mortality in the world, with vascular invasion being one of the most important prognostic factors. HCC with tumor thrombus was traditionally considered to have very limited treatment options. However, multiple promising treatment strategies have emerged in recent years, with diagnostic and interventional radiologists playing a major role in patient management. We provide a comprehensive update on the diagnosis and management of HCC with vascular invasion and the role of the radiologist in this condition.
Literatur
1.
Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon: International Agency for Research on Cancer; 2013, accessed on 8/22/2015. Available from: http://​globocan.​iarc.​fr
2.
3.
Manghisi G, Elba S, Mossa A, et al. (1998) A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients: the Cancer of the Liver Italian Program (CLIP) investigators. Hepatology 28:751–755
4.
Cabibbo G, Enea M, Attanasio M, et al. (2010) A meta-analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma. Hepatology 51:1274–1283CrossRefPubMed
5.
Greten TF, Papendorf F, Bleck JS, et al. (2005) Survival rate in patients with hepatocellular carcinoma: a retrospective analysis of 389 patients. Br J Cancer 92:1862–1868CrossRefPubMedPubMedCentral
6.
Griffin N, Addley H, Sala E, et al. (2012) Vascular invasion in hepatocellular carcinoma: is there a correlation with MRI? Br J Radiol 85:736–744CrossRefPubMedPubMedCentral
7.
Thuluvath PJ (2009) Vascular invasion is the most important predictor of survival in HCC, but how do we find it? J Clin Gastroenterol 43:101–102CrossRefPubMed
8.
Du M, Chen L, Zhao J, et al. (2014) Microvascular invasion (MVI) is a poorer prognostic predictor for small hepatocellular carcinoma. BMC Cancer 14:14–38CrossRef
9.
Subramaniam S, Kelley RK, Venook AP (2013) A review of hepatocellular carcinoma (HCC) staging systems. Chin Clin Oncol 2:33–41PubMed
10.
Chapiro J, Geschwind JF (2014) Hepatocellular carcinoma: have we finally found the ultimate staging system for HCC? Nat Rev Gastroenterol Hepatol 11:334–336CrossRefPubMed
11.
Yau T, Tang VY, Yao TJ, et al. (2014) Development of Hong Kong Liver Cancer staging system with treatment stratification for patients with hepatocellular carcinoma. Gastroenterology 146(1691–700):e3PubMed
12.
Liccioni A, Reig M, Bruix J (2014) Treatment of hepatocellular carcinoma. Dig Dis 32:554–563CrossRefPubMed
13.
Sandrasegaran K, Tahir B, Nutakki K, et al. (2013) Usefulness of conventional MRI sequences and diffusion-weighted imaging in differentiating malignant from benign portal vein thrombus in cirrhotic patients. AJR Am J Roentgenol 201:1211–1219CrossRefPubMed
14.
Roayaie S, Jibara G, Taouli B, Schwartz M (2013) Resection of hepatocellular carcinoma with macroscopic vascular invasion. Ann Surg Oncol 20:3754–3760CrossRefPubMed
15.
Bruix J, Raoul JL, Sherman M, et al. (2012) Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: subanalyses of a phase III trial. J Hepatol 57:821–829CrossRefPubMed
16.
Tsai TJ, Chau GY, Lui WY, et al. (2000) Clinical significance of microscopic tumor venous invasion in patients with resectable hepatocellular carcinoma. Surgery 127:603–608CrossRefPubMed
17.
Roayaie S, Blume IN, Thung SN, et al. (2009) A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma. Gastroenterology 137:850–855CrossRefPubMedPubMedCentral
18.
Maida M, Orlando E, Camma C, Cabibbo G (2014) Staging systems of hepatocellular carcinoma: a review of literature. World J Gastroenterol 20:4141–4150CrossRefPubMedPubMedCentral
19.
20.
Llovet JM, Fuster J, Bruix J (2004) Barcelona-Clinic Liver Cancer Group. The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma. Liver Transpl 10:S115–S120CrossRefPubMed
21.
Keating GM, Santoro A (2009) Sorafenib: a review of its use in advanced hepatocellular carcinoma. Drugs 69:223–240CrossRefPubMed
22.
Zhao Y, Cai G, Zhou L, et al. (2013) Transarterial chemoembolization in hepatocellular carcinoma with vascular invasion or extrahepatic metastasis: a systematic review. Asia Pac J Clin Oncol 9:357–364CrossRefPubMed
23.
24.
Rossi S, Ghittoni G, Ravetta V, et al. (2008) Contrast-enhanced ultrasonography and spiral computed tomography in the detection and characterization of portal vein thrombosis complicating hepatocellular carcinoma. Eur Radiol 18:1749–1756CrossRefPubMed
25.
Rossi S, Rosa L, Ravetta V, et al. (2006) Contrast-enhanced versus conventional and color Doppler sonography for the detection of thrombosis of the portal and hepatic venous systems. AJR Am J Roentgenol 186:763–773CrossRefPubMed
26.
Sorrentino P, D’Angelo S, Tarantino L, et al. (2009) Contrast-enhanced sonography versus biopsy for the differential diagnosis of thrombosis in hepatocellular carcinoma patients. World J Gastroenterol 15:2245–2251CrossRefPubMedPubMedCentral
27.
Ueno N, Kawamura H, Takahashi H, et al. (2006) Characterization of portal vein thrombus with the use of contrast-enhanced sonography. J Ultrasound Med 25:1147–1152PubMed
28.
Tarantino L, Francica G, Sordelli I, et al. (2006) Diagnosis of benign and malignant portal vein thrombosis in cirrhotic patients with hepatocellular carcinoma: color Doppler US, contrast-enhanced US, and fine-needle biopsy. Abdom Imaging 31:537–544CrossRefPubMed
29.
Reynolds AR, Furlan A, Fetzer DT, et al. (2015) Infiltrative hepatocellular carcinoma: what radiologists need to know. Radiographics 35:371–386CrossRefPubMed
30.
Tirumani SH, Shanbhogue AK, Vikram R, Prasad SR, Menias CO (2014) Imaging of the porta hepatis: spectrum of disease. Radiographics 34:73–92CrossRefPubMed
31.
Imaeda T, Yamawaki Y, Hirota K, et al. (1989) Tumor thrombus in the branches of the distal portal vein: CT demonstration. J Comput Assist Tomogr 13:262–268CrossRefPubMed
32.
Tublin ME, Dodd GD 3rd, Baron RL (1997) Benign and malignant portal vein thrombosis: differentiation by CT characteristics. AJR Am J Roentgenol 168:719–723CrossRefPubMed
33.
Mathieu D, Grenier P, Larde D, Vasile N (1984) Portal vein involvement in hepatocellular carcinoma: dynamic CT features. Radiology 152:127–132CrossRefPubMed
34.
McBride K, Masterson J (1992) The thread and streak sign of portal vein tumour thrombus demonstrated by colour Doppler imaging. Br J Radiol 65:607–609CrossRefPubMed
35.
Willatt JM, Hussain HK, Adusumilli S, Marrero JA (2008) MR imaging of hepatocellular carcinoma in the cirrhotic liver: challenges and controversies. Radiology 247:311–330CrossRefPubMed
36.
Catalano OA, Choy G, Zhu A, Hahn PF, Sahani DV (2010) Differentiation of malignant thrombus from bland thrombus of the portal vein in patients with hepatocellular carcinoma: application of diffusion-weighted MR imaging. Radiology 254:154–162CrossRefPubMed
37.
Li C, Hu J, Zhou D, et al. (2014) Differentiation of bland from neoplastic thrombus of the portal vein in patients with hepatocellular carcinoma: application of susceptibility-weighted MR imaging. BMC Cancer 14:590CrossRefPubMedPubMedCentral
38.
Gouw AS, Balabaud C, Kusano H, et al. (2011) Markers for microvascular invasion in hepatocellular carcinoma: where do we stand? Liver Transpl 17(Suppl 2):S72–S80CrossRefPubMed
39.
Sumie S, Kuromatsu R, Okuda K, et al. (2008) Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors. Ann Surg Oncol 15:1375–1382CrossRefPubMed
40.
Nishie A, Yoshimitsu K, Irie H, et al. (2009) Radiological detectability of minute hepatic venous invasion in hepatocellular carcinoma. Eur J Radiol 70:517–524CrossRefPubMed
41.
Nishie A, Yoshimitsu K, Asayama Y, et al. (2008) Radiologic detectability of minute portal venous invasion in hepatocellular carcinoma. AJR Am J Roentgenol 190:81–87CrossRefPubMed
42.
Robinson E, Chandarana H, Droxhinin L, et al. (2009) MRI features of HCC do not predict microvascular invasion in liver transplant for hepatocellular carcinoma [abstract]. Liver Transpl 15(suppl 7):S111
43.
Chandarana H, Robinson E, Hajdu CH, et al. (2011) Microvascular invasion in hepatocellular carcinoma: is it predictable with pretransplant MRI? AJR Am J Roentgenol 196:1083–1089CrossRefPubMed
44.
Kim H, Park MS, Choi JY, et al. (2009) Can microvessel invasion of hepatocellular carcinoma be predicted by pre-operative MRI? Eur Radiol 19:1744–1751CrossRefPubMed
45.
Renzulli M, Brocchi S, Cucchetti A, et al (2015) Can current preoperative imaging be used to detect microvascular invasion of hepatocellular carcinoma? Radiology 150998
46.
Ariizumi S, Kitagawa K, Kotera Y, et al. (2011) A non-smooth tumor margin in the hepatobiliary phase of gadoxetic acid disodium (Gd-EOB-DTPA)-enhanced magnetic resonance imaging predicts microscopic portal vein invasion, intrahepatic metastasis, and early recurrence after hepatectomy in patients with hepatocellular carcinoma. J Hepatobiliary Pancreat Sci 18:575–585CrossRefPubMed
47.
Kim KA, Kim MJ, Jeon HM, et al. (2012) Prediction of microvascular invasion of hepatocellular carcinoma: usefulness of peritumoral hypointensity seen on gadoxetate disodium-enhanced hepatobiliary phase images. J Magn Reson Imaging 35:629–634CrossRefPubMed
48.
Kim MJ, Lee M, Choi JY, Park YN (2012) Imaging features of small hepatocellular carcinomas with microvascular invasion on gadoxetic acid-enhanced MR imaging. Eur J Radiol 81:2507–2512CrossRefPubMed
49.
Vauthey JN, Dixon E, Abdalla EK, et al. (2010) Pretreatment assessment of hepatocellular carcinoma: expert consensus statement. HPB (Oxford) 12:289–299CrossRef
50.
Zhang T, Huang JW, Bai YN, Wu H, Zeng Y (2014) Recurrence and survivals following hepatic resection for hepatocellular carcinoma with major portal/hepatic vein tumor thrombus. Hepatol Res 44:761–768CrossRefPubMed
51.
Klein J, Dawson LA (2013) Hepatocellular carcinoma radiation therapy: review of evidence and future opportunities. Int J Radiat Oncol Biol Phys 87:22–32CrossRefPubMed
52.
Zhu K, Chen J, Lai L, et al. (2014) Hepatocellular carcinoma with portal vein tumor thrombus: treatment with transarterial chemoembolization combined with sorafenib—a retrospective controlled study. Radiology 272:284–293CrossRefPubMed
53.
Llovet JM, Ricci S, Mazzaferro V, et al. (2008) Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 359:378–390CrossRefPubMed
54.
Llovet JM, Villanueva A, Lachenmayer A, Finn RS (2015) Advances in targeted therapies for hepatocellular carcinoma in the genomic era. Nat Rev Clin Oncol 12:436CrossRefPubMed
55.
Xue TC, Xie XY, Zhang L, et al. (2013) Transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: a meta-analysis. BMC Gastroenterol 13:60CrossRefPubMedPubMedCentral
56.
Kim KM, Kim JH, Park IS, et al. (2009) Reappraisal of repeated transarterial chemoembolization in the treatment of hepatocellular carcinoma with portal vein invasion. J Gastroenterol Hepatol 24:806–814CrossRefPubMed
57.
Pinter M, Hucke F, Graziadei I, et al. (2012) Advanced-stage hepatocellular carcinoma: transarterial chemoembolization versus sorafenib. Radiology 263:590–599CrossRefPubMed
58.
Georgiades CS, Hong K, D’Angelo M, Geschwind JF (2005) Safety and efficacy of transarterial chemoembolization in patients with unresectable hepatocellular carcinoma and portal vein thrombosis. J Vasc Interv Radiol 16:1653–1659CrossRefPubMed
59.
Chung GE, Lee JH, Kim HY, et al. (2011) Transarterial chemoembolization can be safely performed in patients with hepatocellular carcinoma invading the main portal vein and may improve the overall survival. Radiology 258:627–634CrossRefPubMed
60.
Kooby DA, Egnatashvili V, Srinivasan S, et al. (2010) Comparison of yttrium-90 radioembolization and transcatheter arterial chemoembolization for the treatment of unresectable hepatocellular carcinoma. J Vasc Interv Radiol 21:224–230CrossRefPubMed
61.
Lance C, McLennan G, Obuchowski N, et al. (2011) Comparative analysis of the safety and efficacy of transcatheter arterial chemoembolization and yttrium-90 radioembolization in patients with unresectable hepatocellular carcinoma. J Vasc Interv Radiol 22:1697–1705CrossRefPubMed
62.
Tsai AL, Burke CT, Kennedy AS, et al. (2010) Use of yttrium-90 microspheres in patients with advanced hepatocellular carcinoma and portal vein thrombosis. J Vasc Interv Radiol 21:1377–1384CrossRefPubMedPubMedCentral
63.
Poon RT, Cheung TT, Kwok PC, et al. (2015) Hong Kong consensus recommendations on the management of hepatocellular carcinoma. Liver Cancer 4:51–69CrossRefPubMedPubMedCentral
64.
Camacho JC, Moncayo V, Kokabi N, et al. (2015) Y90 radioembolization: multimodality imaging pattern approach with angiographic correlation for optimized target therapy delivery. Radiographics 35:1602–1618CrossRefPubMed
65.
Kulik LM, Carr BI, Mulcahy MF, et al. (2008) Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis. Hepatology 47:71–81CrossRefPubMed
66.
Inarrairaegui M, Thurston KG, Bilbao JI, et al. (2010) Radioembolization with use of yttrium-90 resin microspheres in patients with hepatocellular carcinoma and portal vein thrombosis. J Vasc Interv Radiol 21:1205–1212CrossRefPubMed
67.
68.
69.
Shi J, Lai EC, Li N, et al. (2011) A new classification for hepatocellular carcinoma with portal vein tumor thrombus. J Hepatobiliary Pancreat Sci 18:74–80CrossRefPubMed
70.
Shin DS, Ingraham CR, Dighe MK, et al. (2014) Surgical resection of a malignant liver lesion: what the surgeon wants the radiologist to know. AJR Am J Roentgenol 203:W21–W33CrossRefPubMed
71.
May BJ, Talenfeld AD, Madoff DC (2013) Update on portal vein embolization: evidence-based outcomes, controversies, and novel strategies. J Vasc Interv Radiol 24:241–254CrossRefPubMed
72.
Vennarecci G, Laurenzi A, Santoro R, et al. (2014) The ALPPS procedure: a surgical option for hepatocellular carcinoma with major vascular invasion. World J Surg 38:1498–1503CrossRefPubMed
73.
Schnitzbauer AA, Lang SA, Goessmann H, et al. (2012) Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings. Ann Surg 255:405–414CrossRefPubMed
74.
Neeman Z, Libutti SK, Patti JW, Wood BJ (2003) Percutaneous radiofrequency ablation of hepatocellular carcinoma in the presence of portal vein thrombosis. Clin Imaging 27:417–420CrossRefPubMedPubMedCentral
75.
Bujold A, Massey CA, Kim JJ, et al. (2013) Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma. J Clin Oncol 31:1631–1639CrossRefPubMed
76.
Li D, Kang J, Golas BJ, Yeung VW, Madoff DC (2014) Minimally invasive local therapies for liver cancer. Cancer Biol Med 11:217–236PubMedPubMedCentral
77.
Hong TS (2013) Radiotherapy for hepatocellular carcinoma with tumor vascular thrombus: ready for prime time? J Clin Oncol 31:1619–1620CrossRefPubMed
78.
79.
Metadaten
Titel
Clinical implications for imaging of vascular invasion in hepatocellular carcinoma
verfasst von
Akshay D. Baheti
Gregor M. Dunham
Christopher R. Ingraham
Mariam Moshiri
Chandana Lall
James O. Park
David Li
Douglas S. Katz
David C. Madoff
Puneet Bhargava
Publikationsdatum
03.05.2016
Verlag
Springer US
Erschienen in
Abdominal Radiology / Ausgabe 9/2016
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-016-0763-2

Weitere Artikel der Ausgabe 9/2016

Abdominal Radiology 9/2016 Zur Ausgabe

OriginalPaper

Natural history of liver imaging reporting and data system category 4 nodules in MRI

OriginalPaper

Effect of gadolinium contrast-enhanced T1-weighted magnetic resonance imaging for detecting extramural venous invasion in rectal cancer

Pictorial Essay

Colorectal cancer mimics: a review of the usual suspects with pathology correlation

JSAR

A case of pseudomyxoma peritonei: visualization of septa using diffusion-weighted images with low b values

Classics in Abdominal Imaging

The dog ear sign

OriginalPaper

Histogram analysis of noncancerous liver parenchyma on gadoxetic acid-enhanced MRI: predictive value for liver function and pathology

Neu im Fachgebiet Radiologie

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

S3-Leitlinie zu Pankreaskrebs aktualisiert

23.04.2024 Pankreaskarzinom Nachrichten

Die Empfehlungen zur Therapie des Pankreaskarzinoms wurden um zwei Off-Label-Anwendungen erweitert. Und auch im Bereich der Früherkennung gibt es Aktualisierungen.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

13.04.2024 Klinik aktuell Kongressbericht

Die Teilnehmer eines Forums beim DGIM-Kongress waren sich einig: Fehler in der Medizin sind häufig in ungeeigneten Prozessen und mangelnder Kommunikation begründet. Gespräche mit Patienten und im Team können helfen.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise